Kevin Carlton

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Amarendra Pegu, Sarah O’Connell, Stephen D. Schmidt et al. · Science · 2021 · 599 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A proof of concept for structure-based vaccine design targeting RSV in humans

Michelle C. Crank, Tracy J. Ruckwardt, Kaitlyn M. Morabito et al. · Science · 2019 · 340 citations

Life Sciences, Immunology, Infectious Diseases +16

Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults

Martin R. Gaudinski, Emily E. Coates, Katherine V. Houser et al. · PLoS Medicine · 2018 · 253 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Katherine V. Houser, Grace Chen, Cristina Carter et al. · Nature Medicine · 2022 · 163 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +14